Clinical trials: Peritoneal Dialysis Solution Adverse Reaction

Peritoneal Dialysis Solution Adverse Reaction

The Difference Between Daily and Alternative Day Use of Icodextrin

• Unknown status
• Age: 18 to 75 years
• Phase 4

Volume overload is an important cause of technical failure in peritoneal dialysis patients. Icodextrin can provide continuous ultrafiltration, which provides a new option for peritoneal dialysis patients.

Trial name

NCT05943470

Testing

Icodextrin Peritoneal Dialysis Solution

Volunteers

74 people

Sponsor

RenJi Hospital